S
EBS icon

SignatureFD’s Emergent Biosolutions EBS Stock Holding History

SignatureFD’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$478 Sell
57
-242
-81% -$2.02K ﹤0.01% 3366
2026
Q1 		$2.48K Buy
+299
New +$3.1K ﹤0.01% 3009
2024
Q3 		– Sell
-59
Closed -$402 – 3262
2024
Q2 		$402 Hold
59
– – ﹤0.01% 3002
2024
Q1 		$149 Hold
59
– – ﹤0.01% 3115
2023
Q4 		$142 Hold
59
– – ﹤0.01% 3076
2023
Q3 		$201 Hold
59
– – ﹤0.01% 3093
2023
Q2 		$434 Sell
59
-1,423
-96% -$13.2K ﹤0.01% 3080
2023
Q1 		$15.4K Sell
1,482
-489
-25% -$5.91K ﹤0.01% 2013
2022
Q4 		$23.3K Buy
1,971
+1,879
+2,042% +$29.1K ﹤0.01% 1728
2022
Q3 		$2K Sell
92
-115
-56% -$3.2K ﹤0.01% 2761
2022
Q2 		$6K Buy
207
+7
+4% +$239 ﹤0.01% 2361
2022
Q1 		$8K Sell
200
-89
-31% -$3.92K ﹤0.01% 2253
2021
Q4 		$13K Buy
289
+124
+75% +$5.61K ﹤0.01% 1979
2021
Q3 		$8K Buy
165
+110
+200% +$6.66K ﹤0.01% 2169
2021
Q2 		$3K Sell
55
-11
-17% -$707 ﹤0.01% 2440
2021
Q1 		$6K Sell
66
-25
-27% -$2.56K ﹤0.01% 2057
2020
Q4 		$8K Sell
91
-121
-57% -$11.1K ﹤0.01% 1781
2020
Q3 		$22K Buy
212
+157
+285% +$16.9K ﹤0.01% 1324
2020
Q2 		$4K Buy
55
+12
+28% +$894 ﹤0.01% 1876
2020
Q1 		$2K Buy
43
+8
+23% +$461 ﹤0.01% 1923
2019
Q4 		$2K Hold
35
– – ﹤0.01% 1866
2019
Q3 		$2K Hold
35
– – ﹤0.01% 1797
2019
Q2 		$2K Hold
35
– – ﹤0.01% 1747
2019
Q1 		$2K Hold
35
– – ﹤0.01% 1763
2018
Q4 		$2K Hold
35
– – ﹤0.01% 1714
2018
Q3 		$2K Hold
35
– – ﹤0.01% 1679
2018
Q2 		$2K Hold
35
– – ﹤0.01% 1710
2018
Q1 		$2K Buy
+35
New +$1.74K ﹤0.01% 1544

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

SignatureFD's EBS Position: Q2 2026 in Review

SignatureFD reduced its Emergent Biosolutions (EBS) stake by 81% in Q2 2026, selling an estimated $2.02K and leaving 57 shares worth $478. The position accounts for ﹤0.01% of the portfolio, ranked #3366.

SignatureFD first reported a position in EBS in Q1 2018 and has held it in 28 quarters since. The position peaked at $23.3K in Q4 2022. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • SignatureFD held 57 shares of Emergent Biosolutions worth $478 as of Q2 2026.
  • SignatureFD sold 242 Emergent Biosolutions shares in Q2 2026, an estimated $2.02K.
  • Emergent Biosolutions made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3366 holding.
  • SignatureFD first reported a position in Emergent Biosolutions in Q1 2018 and has held it in 28 quarters since.
  • SignatureFD's Emergent Biosolutions position peaked at $23.3K in Q4 2022.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.